The Jak/Stat signaling pathway transmits signals from many cytokine and growth factor receptors to target genes in the nucleus. Constitutive activation of Stat3 has recently been observed in many tumor cells and dysregulation of the Stat signaling pathway has been proposed to be implicated in malignant transformation. In a previous study, we found constitutively tyrosine phosphorylated Stat3 in mycosis fungoides tumor cells. Here, we show that the Jak kinase inhibitor, Ag490, inhibits the constitutive binding of Stat3 to an oligonucleotide representing the Stat-binding sequence from the ICAM promotor. The decreased ability of Stat3 to bind DNA precedes dynamic alterations in the expression of anti-apoptotic Bcl-2 and pro-apoptotic Bax proteins (decreased Bcl-2 expression and increased Bax expression) and induction of apoptosis. Thus, our data suggest that the involvement of Stat3 in oncogenic transformation could be mediated through regulation of survival signals.
Introduction
Activation of Stat proteins (short for signal transducer and activator of transcription) is involved in signaling through most cytokine and growth factor receptors (reviewed in Ref. 1) . The observation of constitutively activated Stat proteins in various types of tumor cells, as well as cells transformed in vitro with v-src or abl oncogenes, has suggested a correlation between constitutive Stat activation and dysregulation of growth. [2] [3] [4] [5] Two recent reports have demonstrated activation of Stat3 to be required for cellular transformation by v-src. 6, 7 Interestingly, Stat3 was shown to be required for Bcl-2 induction and anti-apoptosis in pro-B cells, 8 suggesting that constitutively activated Stat3 could play a role in malignant transformation by decreasing apoptosis. The finding that Stat3 deficiency is embryonically lethal could also indicate a function in regulation of anti-apoptosis/survival. 9 To address whether Stat3 might play a role in the dysregulation of apoptosis in tumor cells, we focused on tumor cells from a patient with mycosis fungoides (MF) a cutaneous T cell lymphoma, which expresses constitutively activated Stat3. 3 Here we show, that treatment of MF cells with the newly identified Jak kinase inhibitor, Ag490, leads to (1) inhibition of the constitutive tyrosine phosphorylation of Stat3; (2) inhibition of DNA-binding of Stat3; (3) dynamic alterations in Bcl-2 and Bax expression; and (4) a subsequent increase in apoptosis. Thus, our data add further support to the idea that Stat3 may be involved in regulation of anti-apoptotic responses. 
Materials and methods

Antibodies and other reagents
Rabbit affinity purified polyclonal anti-Bax Ab (N20) was from Santa Cruz Laboratories (Santa Cruz, CA, USA). Rabbit IgG was from Sigma (St Louis, MO, USA). Mouse IgG 1 , PE conjugated rabbit anti-mouse IgG and FITC conjugated swine antirabbit IgG were from Dako (Glostrup, Denmark). Mouse monoclonal anti-rat Bcl-2 Ab from Immunotech, a Coulter Company (Miami, FL, USA). Stat3 mAb was from Transduction Laboratories (Lexington, KY, USA). Phospho-specific Stat3 (tyr705) Ab was from New England Biolabs (Beverly, MA, USA). Phosphotyrosine mAb (4G10) was from Upstate Biotechnology (Lake Placid, NY, USA). DNA binding dye 7-amino-actinomycin D (7-AAD) was from Sigma and tyrphostin Ag490 was from Alexis Corporation, Switzerland. The doublestranded Stat-binding sequence from the ICAM-promotor used for affinity purification was 5′-Bio-AGCTTAGGTTTCCGG-GAAAGCAC-3′. 10 
Cells
A tumor cell line was established from a plaque biopsy specimen of a patient with MF as described in detail elsewhere. 3, 11 A combinatorial approach that included phenotyping, genotyping, HLA-typing, and karyotyping verified the tumor cell origin of the cell line. 12 The MF tumor cell line used in this study has proliferated beyond 1000 population doublings. The karyotypic changes of the tumor cell line during this continuous culture period has previously been described. 11, 12 MF cells were cultured in RPMI 1640 (Gibco) supplemented with 10% FCS, 2 mM L-glutamine, 100 g/ml penicillin and 100 g/ml streptomycin.
MTT assay
150 l confluent cell culture (triplicate) was transferred to 96-well plate and 25 l MTT solution was added (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide, 5 mg/ml in PBS). The plate was incubated 4 h at 37°C. 100 l of MTTlysis buffer was added and the plate was incubated overnight at 37°C. Conversion of MTT was determined by measuring optical density at 570 nm (OD 570 ).
Oligonucleotide affinity purification or immunoprecipitation of Stat proteins and Western blotting
For analysis of total lysates 3 × 10 6 cells/experiment and 15 × 10 6 cells/experiment for oligonucleotide affinity purification and immunoprecipitation were lysed in ice cold lysis buffer (1% NP-40, 20 mM Tris pH 8.0, 137 mM NaCl, 5 mM MgCl 2 , 10% glycerol and the following inhibitors: 5 mM EDTA, 1 mM Na 3 VO 4 , 10 g/ml aprotinin, 4 M iodoacetamide, 1 mM PMSF). For oligonucleotide affinity purification, 150 pmol of double-stranded biotinylated oligo were added to 1 ml of cellular lysate. Stat/oligonucleotide complexes were recovered using streptavidin-conjugated beads whereas immunoprecipitated proteins were recovered using proteinAcoupled beads. Purified proteins or total lysates were boiled in reducing SDS sample buffer and analyzed by gel electrophoresis followed by electrophoretic transfer to a nitrocellulose membrane. The membrane was blocked in 3% skimmed powder milk, 1% BSA in PBS and incubated with primary Ab in blocking buffer followed by washing in PBS and incubation with peroxidase conjugated secondary antibody. Blots were evaluated using enhanced chemiluminescence (ECL), stripped and reprobed according to the manufacturer's manual (Amersham).
FACS analysis of intracellular antigen expression
Cells were harvested (5 × 10 5 ), washed once with PBS, resuspended in 2% paraformaldehyde in PBS, and then incubated on ice for 10 min. After fixation, the cells were washed once in PBS, resuspended in PBS containing 0.2% saponin and 10% swine serum (Bax) or FCS (Bcl-2), and then incubated for 10 min at room temperature. The cells were pelleted, resuspended in 100 l of saponin staining buffer (0.2% saponin, 2% FCS in PBS) containing primary Ab (5 g/ml), and incubated for 30 min at room temperature. The cells were washed once in staining buffer (2% FCS in PBS), resuspended in saponin staining buffer containing FITC labelled swine antirabbit IgG (1:20) or PE labelled rabbit anti-mouse IgG (1:20) and incubated for 30 min at room temperature. The cells were washed twice in staining buffer and stored at 4°C until they
Figure 1
Ag490 inhibits constitutive Stat3 phosphorylation on tyrosine and blocks binding to DNA. MF cells were incubated overnight with the indicated concentrations of Ag490 or DMSO (solvent) in the same relative concentrations. In (a), cells were lysed and total lysates were subjected to Western blotting using Ab recognizing tyrosine phosporylated Stat3 (PY-Stat3). As a control for drug specificity the membrane showing Ag490 treated lysates was stripped and reprobed with anti-phosphotyrosine mAb. Only part of the gel, showing a phosphorylated protein at 30 kDa unaffected by ag490 incubation, is shown. In (b), DNA-binding Stat proteins were affinity-purified using a biotinylated ICAM probe and analyzed by Western blotting with Stat3 mAb. These data were representative from at least three independent experiments.
were analyzed on a FACScan (Becton Dickinson). Usually 10 4 cells were analysed.
Quantification of apoptotic cells
Apoptotic cells were quantified by the use of the DNA binding dye 7-amino-actinomycin D (7-AAD). Cells were harvested (5 × 10 5 ), washed once with PBS, resuspended in 0.5 ml 0.05% saponin in PBS, and pelleted. The cells were resuspended in 0.5 ml 4 g/ml 7-AAD in 0.05% saponin in PBS and incubated at room temperature in the dark. Untreated cells were used to set gates for viable cells with 2N-4N DNA, for apoptotic cells with subnormal DNA content, and for exclusion of debris.
Results and discussion
Ag490 inhibits constitutive binding of Stat3 to DNA
As shown previously 3 and confirmed here, Ag490 inhibits constitutive tyrosine phosporylation of Stat3 in malignant T cell lines established from a patient with MF ( Figure 1a) . In order to examine the ability of Stat3 to bind DNA after Ag490 treatment of the cells, affinity purification with a biotinylated oligonucleotide probe representing a Stat-binding sequence from the ICAM promotor was performed. Immunoblotting of the purified proteins with anti-Stat3 antibody, clearly demonstrated that Ag490 treatment blocked the DNA-binding capability of Stat3 (Figure 1b) . Toxic effects from the solvent used to dissolve Ag490 could be excluded since cells incubated with the same relative concentration of DMSO alone showed no inhibition of Stat3 (Figure 1a and b) . The specificity of the drug was further demonstrated by stripping the membrane previously blotted with PY-Stat3 Ab and reprobing it with mAb against phosphotyrosine. In lysates from untreated MF cells, the predominant tyrosine phosphorylated proteins are detected at approximately 125 kDa, 92 kDa (Stat3), 55 kDa and 30 kDa (data not shown). Following Ag490 treatment only tyrosine phosphorylation of Stat3 is strongly inhibited, whereas tyrosine phosphorylation of other proteins are only insignificantly inhibited or not inibited at all. This is demonstrated in Figure 1a (lower) , where tyrosine phosphorylation of the 30 kDa protein is unaffected by Ag490 treatment.
Expression of Bcl-2 and Bax proteins is altered following Ag490 treatment
Considering that Stat3 has been suggested to be implicated in anti-apoptotic signaling, 8 we wanted to examine the expression of the anti-apoptotic protein Bcl-2 and the proapoptotic protein Bax in MF cells treated with Ag490. In order to analyze whether Ag490 treatment of MF cells affected the expression of Bcl-2 and Bax, FACS analysis was performed. As shown in Figure 2a and b, alterations in the expression of Bcl-2 and Bax were induced after 2 days of Ag490 incubation. The level of Bcl-2 expression in Ag490 treated cells declined to 54% as compared to cells incubated in medium. In contrast, expression of Bax increased to 128% in Ag490 treated cells as compared to cells incubated in medium (Figure 2b) . Incubation of cells in the highest concentration of solvent (DMSO) did not influence expression of Bax and Bcl-2 proteins. Thus, these observations are in accordance with findings in other cell systems, where inhibition of Stat3 signaling lead to decreased Bcl-2 expression. 8, 13 The counter-acting proteins Bcl-2 and Bax, play a key role in regulation of apoptosis.
14 High levels of Bcl-2 have a function in maintaining the normal ion potential across the mitochondrial membrane. 15 However, in situations where expression of Bax is increased, heterodimers of Bcl-2 and Bax are formed resulting in a collapse of the mitochondrial membrane and finally induction of apoptosis. 15 Thus, the balance between expression of Bax and Bcl-2 is considered very important in determining susceptibility to apoptosis.
Inhibition of Stat3 activity and changes in Bcl-2/Bax expression are followed by induction of apoptosis
In order to examine cell viability after Ag490 treatment, an MTT assay was used. This assay measures mitochondrial activity and therefore can be used to measure cell viability. As shown in Figure 3a , MF cells incubated with increasing concentrations of Ag490 for 4 days displayed a strongly decreased MTT conversion compared to non-treated cells. Whether the decreased mitochondrial activity was due to induction of apoptosis was examined using the DNA-binding dye 7-AAD (Figure 3b and c) . Ag490 induced a strong apoptotic response in MF cells, ie the percentage of apoptotic cells was gradually increased to 35% during 4 days of Ag490 treatment (Figure 3b ). Compared to MF cells incubated in medium containing the relevant amounts of DMSO for 4 days, this is approximately a four-fold increase in apoptosis. In Figure 3c , original FACS-data from day 4 are depicted. The gates used for quantifying the apoptotic and total numbers of cells have been included. Thus, Ag490-induced inhibition of constitutively activated Stat3 is followed by changes in Bcl-2/Bax expression and induction of apoptosis. Considering findings in other cell systems, where Stat3 inhibition was shown to decrease Bcl-2 expression and induce apoptosis, 8, 13 we speculate that the Ag490-induced effects are mediated via inhibition of constitutively activated Stat3. However, we can not exclude that other Jak kinase targets might be involved. Although Stat3 is constitutively associated with Jak3, we have not been able to detect any constitutive tyrosine phosphorylation of Jak3 or other kinases in MF cells. 3 It is therefore possible that Jak kinases are acting as docking proteins, and that the Ag490 effects in that way are mediated via Jak kinases. Studies are in progress aiming at identifying the putative Ag490-sensitive kinase.
Dysregulation of the apoptotic signaling pathway is believed to play an important role in malignant transform-
Figure 3
Ag490-mediated inhibition of Stat3 and changes in Bcl-2/Bax expression are followed by induction of apoptosis. MF cells were incubated with Ag490 or medium containg the relevant amount of DMSO (solvent) for the indicated periods of time. Cell cultures were subsequently subjected to (a) MTT analysis for measuring cell viability after 4 days of incubation, or (b) and (c) quantification of apoptotic cells using the fluorescent DNA-binding dye 7-AAD. In (c), histograms from day 4 are shown including the gates used for determining the numbers of apoptotic and viable cells. These data are representative from four independent experiments. ation. Our data, seen in connection with data from other groups, suggest that Stat3 is involved in regulation of antiapoptosis. These findings imply that inhibition of constitutively activated Stat pathways could provide new means of cancer treatment. The therapeutic potential of Ag490 has recently been substantiated by an in vivo study. 16 In this study, administration of Ag490 was shown to block actively induced experimental autoimmune encephalomyelitis (EAE), the animal model for multiple sclerosis. Thus, the Jak/Stat signaling pathway holds great promise as target for pharmaceutical intervention.
